While controversy remains regarding whether the levels of GNMT in clinical PCa samples are downregulated [112] or upregulated [113], it is clear that dysregulation of GNMT may reflect changes in AR activity and ERG fusion status during PCa establishment and progression. This evidence concerns the gene AR and posterior cortical atrophy.